CBP-403

N/A

Report date: 2023/10/07 14:57:26

Base Information

Drug NameCBP-403
Drug Alias NameCBP-403
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Connect Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Connect Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A